Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Avery Dennison Materials Group Names Hassan Rmaile Global Vice President, R&D

Avery Dennison Corporation (NYSE:AVY) today announced the appointment of Hassan Rmaile as the Global Vice President of R&D for its Materials Group effective immediately.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

He replaces Sjaak Elmendorp, who will be retiring from the company after 22 years of valued service.

As Global VP for R&D, Rmaile will oversee the Materials Group's extensive global R&D network and focus on identifying new, disruptive applications while continuing to grow the performance and cost attractiveness of the core business.

Rmaile is joining Avery Dennison from St. Paul, Minnesota-based H.B. Fuller Company, a global industrial adhesives manufacturer, where he served as vice president, chief technology and innovation officer. Prior to joining H.B. Fuller, Rmaile held roles of increasing commercial and innovation leadership at Ashland Incorporated, a specialty chemical company.

"Hassan brings a strong track record of global R&D leadership and proven success in the commercialization of new technologies and products while enhancing overall profitability for the business," said Georges Gravanis, president, Avery Dennison Materials Group. "He is an experienced global innovation leader in multiple sectors of the specialty chemicals market."

Rmaile earned his PhD in chemistry from Florida State University, an MBA in finance from the University of Delaware and graduated with a BS in Chemistry from American University of Beirut, Lebanon.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?